TATX-61

N/A

Report date: 2025/10/27 17:55:43

Base Information

Drug NameTATX-61
Drug Alias NameTATX-61
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionFolate receptor beta modulators
TargetsFolate receptor beta
Therapy Area/IndicationsOpportunistic Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTalem Therapeutics LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOpportunistic Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A